Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Oral semaglutide and reduction in major adverse cardiovascular events. | Pepdox

Home
Search
PMID 40250965

Oral semaglutide and reduction in major adverse cardiovascular events.

Journal of clinical lipidology2025PMID: 40250965

View on PubMed DOI: 10.1016/j.jacl.2025.04.001

Authors

Barton Duell, P; Maki, Kevin C